| Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine (NCT05371353) | Shanghai Bovax Biotechnology Co., Ltd. | 2022-05-14 |
| Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years (NCT05027776) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-09-15 |
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-05-28 |
| Education, Immigration and HPV Vaccination: an Informational Randomized Trial (NCT04905030) | Karolinska Institutet | 2021-04-28 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-09-19 |
| Genital Wart and Sexuality in Adolescence (NCT04796090) | Ankara City Hospital Bilkent | 2020-08-01 |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-05-28 |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-04-28 |
| Safety and Efficacy of Laser Therapy in Gynaecology (NCT04073082) | Juna d.o.o. | 2019-07-24 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101) | Shanghai Bovax Biotechnology Co., Ltd. | 2018-10-10 |
| Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients (NCT03153566) | Assiut University | 2017-06-01 |
| Low Dose Cyclophosphamide Treats Genital Warts (NCT00999986) | Huazhong University of Science and Technology | 2007-01-01 |